Search Orphan Drug Designations and Approvals
-
Generic Name: | glucagon-like peptide-1/glucagon/gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment |
---|---|
Date Designated: | 05/10/2021 |
Orphan Designation: | Treatment of idiopathic pulmonary fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Hanmi Pharmaceutical Co., Ltd. 14 Wiryeseong-daero Songpa-gu Seoul 05545 South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-